Old Web
English
Sign In
Acemap
>
authorDetail
>
Mihail Obrocea
Mihail Obrocea
Biology
Cirrhosis
Immunology
Acute pancreatitis
Pancreatitis
2
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract C18: A phase I study of enavatuzumab (PDL192, ABT-361), a first-in-class human monoclonal antibody targeting TWEAK (tumor necrosis factor-like inducer of apoptosis) receptor, in patients (Pts) with advanced solid tumors.
2011
Molecular Cancer Therapeutics
Elaine T. Lam
S. Gail Eckhardt
Wells A. Messersmith
Antonio Jimeno
Cindy L. O'Bryant
Ramesh K. Ramanathan
Glen J. Weiss
Manpreet Chadha
Monica Fulk
Ranay Yarian
Abbie Oey
Han Ting Ding
Patricia A. Culp
Teresa Parli
Claire Tsao
Anil K. Singhal
Mihail Obrocea
Kyle D. Holen
Daniel D. Von Hoff
Show All
Source
Cite
Save
Citations (1)
An HPLC method for the measurement of 5-fluorouracil in human plasma with a low detection limit and a high extraction yield
2002
International Journal of Molecular Medicine
Mark Adel. Nassim
Farshad H. Shirazi
C. Cripps
Shereeni Veerasinghan
Matshela J. Molepo
Mihail Obrocea
Diedre Redmond
Susan Bates
Diane Fry
David J. Stewart
Rakesh Goel
Show All
Source
Cite
Save
Citations (19)
1